1. Division of Molecular Target and Gene Therapy Products; National Institute of Health Sciences; 1-18-1 Kamiyoga Setagaya-ku Tokyo 158-8501 Japan
2. Faculty of Life and Medical Sciences; Doshisha University; 1-3 Miyakotani Tatara Kyotanabe Kyoto 610-0394 Japan
3. Department of Applied Chemistry; Tokyo University of Science; 1-3 Kagurazaka Shinjuku-ku Tokyo 162-8601 Japan
4. Division of Molecular Pharmacology; Cancer Chemotherapy Center; Japanese Foundation for Cancer Research; 3-8-31 Ariake Koto-ku Tokyo 135-8550 Japan
5. Center for Product Evaluation; Pharmaceuticals and Medical Device Agency; Shin-Kasumigaseki Building 3-3-2 Kasumigaseki Tokyo 100-0013 Japan